HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer

doi:10.3748/wjg.v21.i46.13004

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7696)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-11) series.

Item

Count

PDF

633

WORD

462

HTML

4849

Figures (1-11)

396

Sum=6340

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

536

Download

820

Sum=1356

Dec 14, 2015 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Dec 14, 2015; 21(46): 13004-13019
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13004

Full Size Figure Download Figure

Figure 8 Colony formation of pancreatic cancer cells (crystal violet). A: The colony formation (CV analysis) in 12-well plates; B: Quantitative CV analysis showed that cell surface coverage area was decreased in cells treated with GEM IC₅₀ after HuR siRNA transfection compared with cells treated only with GEM IC₅₀. HuR: Human antigen R; CV: Crystal violet.

Citation: Jakstaite A, Maziukiene A, Silkuniene G, Kmieliute K, Gulbinas A, Dambrauskas Z. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. World J Gastroenterol 2015; 21(46): 13004-13019
URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13004.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13004